HEM Pharma Inc. (KOSDAQ:376270)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,300
+600 (0.96%)
At close: Apr 9, 2026
Market Cap451.10B +188.6%
Revenue (ttm)12.98B -13.9%
Net Income-23.84B
EPS-3,389.00
Shares Out7.17M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,795
Average Volume30,070
Open62,800
Previous Close62,700
Day's Range61,500 - 64,300
52-Week Range18,000 - 97,500
Betan/a
RSI39.24
Earnings DateMay 28, 2026

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376270
Full Company Profile

Financial Performance

Financial Statements